Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021)

Insight Molecular Diagnostics (IMDX) posted Acquisitions of $607000.0 for Q1 2021, down 90.19% sequentially from $6.2 million in Q1 2020, and down 90.19% YoY from $6.2 million in Q1 2020.

Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021) Analysis & Trends

Insight Molecular Diagnostics (IMDX) has 2 years of Acquisitions data on file, last reported at $607000.0 in Q1 2021.

  • Quarterly Acquisitions fell 90.19% year-over-year to $607000.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $607000.0 (down 90.19% YoY) and the FY2021 annual result came in at $607000.0, down 90.19% from the prior year.
  • Acquisitions fell to $607000.0 in Q1 2021 per IMDX's latest filing, from $6.2 million in the prior quarter.
  • The five-year high for Acquisitions was $6.2 million in Q1 2020, with the low at $607000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn 144.00 Mn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn 8.87 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn -
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn -
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn -
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn 37.00 Mn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn 415.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn 2.24 Mn
10 Insight Molecular Diagnostics 196.41 Mn 167.48 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2021 607,000.00
Mar 31, 2020 6.19 Mn